22 Mar 2007 Phase II/III pivotal study with trifunctional antibody removab(R) shows encouraging results in malignant ascites from various cancers
22 Mar 2007 Emergent BioSolutions Files Investigational New Drug Application With FDA for Pivotal Anthrax Immune Globulin Clinical Trial
21 Mar 2007 Pain Therapeutics Cleared to Initiate Phase I Study in Metastatic Melanoma
17 Mar 2007 FDA Approves Alexion's Soliris(TM) for All Patients With PNH
17 Mar 2007 Micromet and TRACON Pharmaceuticals Sign Exclusive Worldwide License Agreement to Develop and Commercialize D93, a Humanized Antibody for Cancer Treatment
17 Mar 2007 Genmab in Research Cooperation with the Dahanca-Group
13 Mar 2007 Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients With Relapsing Multiple Sclerosis
13 Mar 2007 Symphogen and Biovitrum Initiate Phase 1 Clinical Trial with The First Recombinant Polyclonal Antibody to Enter Clinical Evaluation
13 Mar 2007 TopoTarget Executes Its Licensing Option for the Development of Zemab for Breast Cancer
13 Mar 2007 Protherics to receive £10 million milestone from AstraZeneca
13 Mar 2007 New Insights Into Novel Mechanisms of Action of Genmab's HuMax-EGFr
08 Mar 2007 MAT Biopharma Announced Today the Initiation of the Phase I/II Escalating Dose of Ferritarg P(R)
07 Mar 2007 Kyowa Hakko Kogyo Co., Ltd. Licenses its in-house developed antibody KW-2871 targeting malignant melanoma to Life Science Pharmaceuticals in the US.
01 Mar 2007 XOMA and Takeda Expand Collaboration for Therapeutic Antibody Discovery and Development
28 Feb 2007 Cytogen Announces Initiation of Phase 1 Trial for Radiolabeled Antibody for the Treatment of Hormone-Refractory Prostate Cancer
28 Feb 2007 Vaccinex Announces Antibody Development And Commercialization Alliance In Multiple Sclerosis And Oncology
28 Feb 2007 EvoGenix and Vegenics announce collaboration
28 Feb 2007 HUMIRA(R) (Adalimumab) Receives FDA Approval For Treatment of Crohn's Disease
27 Feb 2007 Positive recommendation for Avastin use in advanced or recurrent colorectal cancer in Japan
24 Feb 2007 Avastin receives positive opinion in Europe for first-line treatment of women with metastatic breast cancer
23 Feb 2007 Significant Phase III Results with CIMZIA(TM) in Rheumatoid Arthritis
23 Feb 2007 New phase III study confirms positive outcome of Avastin in patients with advanced lung cancer
23 Feb 2007 Cell Genesys and Medarex Announce Encouraging Follow-Up Results from a Phase 1 Combination Therapy Trial With GVAX Immunotherapy for Prostate Cancer and Ipilimumab (MDX-010) Antibody
15 Feb 2007 Viventia Biotech provides update on cancer antibody clinical development programs
15 Feb 2007 Peregrine Pharmaceuticals Reports Positive Phase Ib Results for its Targeted Immunotherapy Bavituximab in Chronic Hepatitis C Infection

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up